AVHHL - AVITA Therapeutics Inc. (RCEL) CEO Michael Perry on Q1 2021 Results - Earnings Call Transcript

AVITA Therapeutics, Inc. (RCEL) Q1 2021 Earnings Conference Call November 10, 2020, 16:30 PM ET Company Participants Caroline Corner - Westwicke Partners, Managing Director Michael Perry - Chief Executive Officer Sean Ekins - Vice President, Finance Conference Call Participants Josh Jennings - Cowen Ryan Zimmerman - BTIG Kevin DeGeeter - Oppenheimer Brooks O'Neil - Lake Street Capital John Hester - Bell Potter Lyanne Harrison - Bank of America Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the AVITA Therapeutics Fiscal First Quarter 2021 Earnings Conference Call. At this time, all participants’ lines are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised the today's conference is being recorded. [Operator Instructions] I'd now like to turn the conference over to your speaker today, Caroline Corner, Managing Director. Thank you. Please go ahead ma'am. Caroline Corner Thank

For further details see:

AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry on Q1 2021 Results - Earnings Call Transcript